Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Permian Resources Corporation Announces Secondary Public Offering and Purchase Agreement

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Renewable-energy
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Permian Resources Corporation made a significant announcement on March 4, 2024, regarding a secondary public offering. They disclosed the pricing of 48.5 million shares of their Class A Common Stock at $15.76 per share. The offering is being conducted by specific affiliates and members of the company’s management, with Permian Resources itself not participating in the sale of any shares. Furthermore, Permian Resources Corporation has also agreed to buy 2 million common units from select Selling Stockholders in Permian Resources Operating, LLC, at a price per unit matching the offering price for Class A common stock.

PR Stock Experiences Slight Decline on March 4, 2024 – Potential Buying Opportunity for Investors

On March 4, 2024, PR stock experienced a slight decline in its performance. The stock opened at $15.63, which was $0.42 lower than its previous close. Throughout the trading day, the price of PR shares decreased by $0.39, resulting in a 2.40% drop in value.

Despite this decrease, PR is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing relatively well over the long term, even with the recent decline in price.

Investors may be keeping a close eye on PR stock to see if it can regain some of its lost value in the coming days. The slight drop in price on March 4 may present a buying opportunity for those looking to invest in PR at a lower price point.

PR Stock Performance Analysis: Revenue Surges, Net Income Declines

On March 4, 2024, PR stock saw mixed performances based on the financial data provided by CNN Money. The company reported total revenue of $3.12 billion for the past year, showing an impressive increase of 46.43% compared to the previous year. However, the total revenue remained flat at $1.12 billion for the last quarter.

In terms of net income, PR reported a net income of $476.31 million for the past year, which represented a decrease of 7.52% compared to the previous year. Similar to total revenue, the net income also held flat at $255.35 million for the last quarter.

Earnings per share (EPS) for PR stock stood at $1.24 for the past year, showing a decrease of 23.21% compared to the previous year. The EPS remained flat at $0.51 for the last quarter.

Overall, the financial performance of PR stock on March 4, 2024, showed a mix of positive and negative trends. While the company managed to achieve significant growth in total revenue compared to the previous year, the net income and EPS saw declines. The flat performance in the last quarter indicates that the company may be facing some challenges in maintaining its growth momentum.

Investors and analysts will be closely monitoring PR stock in the coming months to see if the company can address the issues affecting its profitability and EPS. Any updates on strategic initiatives or financial performance could have a significant impact on the stock’s performance in the future.

Tags: PR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Quoin Pharmaceuticals Receives FDA Approval for Teenage Trials of QRX003 for Netherton Syndrome

Finances (2)

Analyst Reiterates InLine Rating on CubeSmart with Increased Price Target

OHI stock news

Analyst at Citigroup Raises Price Target for APi Gr to 43

Recommended

BigBearai Holdings Stock

BigBear.ai Faces Critical Test as Revenue Plummets and Losses Mount

6 months ago
D-Wave Quantum Stock

D-Wave Quantum: CFO’s Multi-Million Dollar Exit Amidst Major Capital Raise

4 months ago
Brightcove Stock

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

6 months ago
Microsoft Stock

Microsoft Faces Critical Earnings Test Amid AI Expectations

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

Trending

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

by SiterGedge
March 25, 2026
0

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant...

Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon
  • Ocugen Shares Slide Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com